Christopher E Kubasik Form 4 L3HARRIS / CHRISTOPHER E KUBASIK ownership change

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0287
Estimated average burden
hours per response:	0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

KUBASIK CHRISTOPHER E

(Last) (First) (Middle)

C/O L3HARRIS TECHNOLOGIES, INC.

1025 W. NASA BOULEVARD

(Street)

MELBOURNE FL 32919

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
L3HARRIS TECHNOLOGIES, INC. /DE/ [ LHX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
Vice Chair, President and COO

3. Date of Earliest Transaction (Month/Day/Year)
02/26/2021

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option (Right to Buy)	$181.91	02/26/2021		A		65,228		02/26/2024(1)	02/26/2031(1)	Common Stock, Par Value $1.00	65,228	$0.00	65,228	D
Restricted Stock Units	$0.00	02/26/2021		A		15,118		(2)	(2)	Common Stock, Par Value $1.00	15,118	$0.00	15,118	D
Performance Stock Units	$0.00	02/26/2021		A		30,235		(3)	(3)	Common Stock, Par Value $1.00	30,235	$0.00	30,235	D

Explanation of Responses:

1. Grant of options to purchase shares of Issuer's common stock subject to future vesting and exercisability: 21,743 on first anniversary of grant date, additional 21,743 on second anniversary of grant date and remaining 21,742 on third anniversary of grant date.

2. Award of restricted stock units subject to future vesting on 2/26/2024. Each restricted stock unit represents a contingent right to 1 share of Issuer's common stock, with vested units settled in shares of Issuer's common stock.

3. Award of performance stock units subject to future vesting on 12/29/2023 in respect of 3-fiscal-year performance period that started 1/2/2021 and also subject to future adjustment based on award payout formula. Each performance stock unit represents a contingent right to 1 share of Issuer's common stock, with vested units settled in shares of Issuer's common stock.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney

	By: /s/ Robert A. Johnson Jr., Attorney-in-Fact For: Christopher E. Kubasik	03/02/2021
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.